Navigation Links
VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
Date:1/16/2008

- Industry Veteran Joins Company as Lead Product Progresses in Phase 2

Trials -

SAN FRANCISCO, Jan. 16 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that Rebecca A. Taub, M.D. has joined VIA as senior vice president of research and development. Dr. Taub brings extensive experience as a pharmaceutical executive heading up major development programs in metabolic diseases as well as more than 15 years as a principal investigator at major academic medical centers.

"Becky will be able to make immediate contributions to VIA. She will play a critical role in defining and implementing the overall strategy at VIA and we are thrilled to have someone with her breadth of experience join our senior management team," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals. "Becky, along with our strong existing team, will contribute to the clinical and commercial development of our lead product candidate VIA-2291, which is in multiple Phase 2 trials investigating its potential to treat vascular inflammation. In addition, she will work in developing strategies for establishing rapid and convincing proof-of-concept clinical studies for additional product candidates, including helping us assess the potential of products currently in our pre-clinical pipeline. Studies show there is a strong link between metabolic diseases and cardiovascular diseases, and we believe that Becky's background and experiences are ideally suited to VIA."

Dr. Taub joins VIA from Roche Pharmaceuticals, a unit of Roche Holding Ltd., where she has served as vice presi
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
2. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
3. QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference
4. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
5. Intercept Pharmaceuticals Names Dr. Luciano Adorini Chief Scientific Officer
6. Onyx Pharmaceuticals to Present at JPMorgan Healthcare Conference
7. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
8. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
9. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
10. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
11. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyt...oldt, PhD to its Board of Directors. Dr. Moldt wil...tative on the Company,s Board. The number of Board...We are very pleased to welcome Peter Moldt to the ...rience and guidance as Cytochroma continues to mak...
(Date:11/24/2009)..., , HOUSTON, Nov. 24 /PRNewswire-FirstC...rovider of electrical and communications systems a...idential markets, announced today that its commerc...m Manhattan Torcon JV to install the electrical sy...cement facility at the U.S. Army Medical Research ...
(Date:11/24/2009)..., , REYKJAVIK, Iceland, No...s, Inc. (Nasdaq: DCGN ) today announced that it ha...t trading in the company,s common stock will be,su...will be filed with the,Securities and Exchange Com...rom listing on Nasdaq, unless the company files an...
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewsw..., a biopharmaceutical company focused on developin...ies, announced today that Anthony DiTonno, Preside...esent at the 21st Annual Piper Jaffray Health Care...New York Palace Hotel in New York, New York. ,...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...esearchers at MIT and Texas Instruments have unvei...t can be up to 10 times more energy-efficient than... phones, implantable medical devices and sensors t... The innovative design will be presented Feb. 5 a...e in San Francisco by Joyce Kwong, a graduate stud...
...Side Branch Stent obtains CE Mark approval based o...n-Man Study) with No Side-Branch R... Tryton Medical, Inc., the leading,developer of st...tion,lesions announced that the company has receiv... Tryton Side-Branch Stent is a high performance,co...
...b. 4 Rochester Medical,Corporation (Nasdaq: ROCM...,quarter ending December 31, 2007., The Company r...r,compared to $7,512,000 for the first quarter of ... or $.02 per diluted share compared to a net incom...e first quarter of last,year. Net income for the f...
Other Biology Technology:Team develops energy-efficient microchip 2Tryton Medical Receives CE Mark Approval for its Side-Branch Stent 2Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 2Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 3Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 4Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 5Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 6Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 7
(Date:11/25/2009)..., Head of the Cell Death Research Laboratory in th... been awarded the prestigious Johnson & Johnson Fo... cause of brain cell damage in Parkinson,s disease...sts in support of innovation and excellence in sci...red earlier this month at an event at the Hyatt Re...
(Date:11/24/2009)...ars it has been prescribed by traditional healers ...hes and stomach pain to fever and flu. , Now for ...y have been able to scientifically prove the pain ...e known as Brazilian mint. , Testing this ancient...archer Graciela Rocha was able to show that when p...
(Date:11/24/2009)...tion of a remarkable class of ring-shaped protein ...Lawrence Berkeley National Laboratory (Berkeley La...y beamline at the Advanced Light Source (ALS). The...ssion and replication, and are vital to the surviv...agents, such as the human papillomavirus, which ha...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 6448 1ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 6448 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 6448 3Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 1Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 2Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 3MINDlink Foundation Launches to Connect the Cerebellum to Cures 61870 1MINDlink Foundation Launches to Connect the Cerebellum to Cures 61870 2
...merhaven, March 24th 2009. The research aircraft P... will start on Monday March 30th at 10 o,clock fro...asurement campaign which will last about four week...ic variables in an area between Spitsbergen, Green... of the project PAM-ARCMIP (Pan-Arctic Measurement...
... research published by a Queen,s University Belfas...in but that they retain a memory of it. , The stu...to small electric shocks, was carried out by Profe...f Biological Sciences at Queen,s and has been publ...sor Elwood, who previously carried out a study sho...
...cksburg, Va. Researchers have unveiled the evolut...ctures found in three species of Agrobacterium. A ...ence information with the genome sequences of othe... chromosomes are formed in bacteria.* , Agrobacte...also includes the benign, nitrogen-fixing organism...
Other Biology News:Research plane Polar 5 on Arctic campaign 2Crabs' memory of pain confirmed by Queen's academic 2Evolutionary origin of bacterial chromosomes revealed 2
...reedom EVOlyzer is Tecans new Enzyme-Linked Immuno...mated microplate processing. Freedom EVOlyzer is a...ng and includes state-of-the art reader, washer an...ed EVOlyzer software. The Freedom EVOlyzer is avai...
...ins are polypeptide hormones which belong to the t... TGF- superfamily is a large group of extra-cellul...velopment, reproductive function and tumor formati...etic proteins, growth differentiation factors, AMH...
...read Plating Beads Sterile plating in just secon...rdous ethanol flaming, More uniform spreading and...le packaging: dispenser bottle for spreading 100 p...t and easiest way to spread cells on multiple plat...
...aboratories working in a regulated environment, Pi...software that automates gravimetric pipette calibr...eets todays regulatory compliance requirements. Pi...es a full security implementation, support for Ora...
Biology Products: